0001562180-23-008506.txt : 20231220 0001562180-23-008506.hdr.sgml : 20231220 20231220161337 ACCESSION NUMBER: 0001562180-23-008506 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231218 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linetsky David CENTRAL INDEX KEY: 0001776729 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38977 FILM NUMBER: 231501464 MAIL ADDRESS: STREET 1: C/O PHREESIA, INC. STREET 2: 432 PARK AVENUE S., 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phreesia, Inc. CENTRAL INDEX KEY: 0001412408 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 1521 CONCORD PIKE STREET 2: SUITE 301 PMB 221 CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 888-654-7473 MAIL ADDRESS: STREET 1: 1521 CONCORD PIKE STREET 2: SUITE 301 PMB 221 CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: Phreesia Inc DATE OF NAME CHANGE: 20070914 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-12-18 false 0001412408 Phreesia, Inc. PHR 0001776729 Linetsky David C/O PHREESIA, INC. 1521 CONCORD PIKE, SUITE 301 PMB 221 WILMINGTON DE 19803 false true false false SVP, Life Sciences false Common Stock 2023-12-18 4 S false 234.00 23.1527 D 7598.00 I By Spouse Common Stock 2023-12-19 4 S false 25.00 23.723 D 7573.00 I By Spouse Common Stock 215036.00 D These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.96 to $23.33 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.595 to $23.84 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Allison Hoffman by Power of Attorney for David Linetsky 2023-12-20